Table 1. Clinical characteristics of patients with dilated cardiomyopathy.
| RNA-seq | TH levels | ||
|---|---|---|---|
| DCM (n = 13) | DCM (n = 23) | P-value | |
| Age (years) | 51±11 | 51±13 | 0.992 |
| Gender male (%) | 92 | 70 | 0.115 |
| NYHA class | 3.4±0.4 | 3.3±0.4 | 0.653 |
| BMI (kg/m2) | 27±5 | 26±5 | 0.378 |
| Total cholesterol (mg/dL) | 147±37 | 133±41 | 0.393 |
| Prior hypertension (%) | 17 | 17 | 1.0 |
| Prior diabetes mellitus (%) | 17 | 20 | 0.815 |
| Hemoglobin (mg/mL) | 13±3 | 12±3 | 0.474 |
| Hematocrit (%) | 39±8 | 37±9 | 0.445 |
| Duration of disease (months) | 75±68 | 77±66 | 0.933 |
| Echo-Doppler study | |||
| EF (%) | 20±7 | 21±10 | 0.578 |
| LVESD (mm) | 71±12 | 68±12 | 0.265 |
| LVEDD (mm) | 80±11 | 76±11 | 0.216 |
| LVMI (g/m2) | 241±77 | 216±68 | 0.245 |
Data are showed as the mean value ± standard deviation. DCM, dilated cardiomyopathy; TH, thyroid hormone; NYHA, New York Heart Association; BMI, body mass index; EF, ejection fraction; LVESD, left ventricular end-systolic diameter; LVEDD, left ventricular end-diastolic diameter; LVMI, left ventricular mass index.